Active ingredient : Cytarabine Cytarabine
CYTOSAR-U INJECTION is a potent and effective medication used primarily in the treatment of certain types of cancer, including acute myeloid leukemia (AML) and meningeal leukemia. This injectable formulation contains cytarabine, which is a chemotherapy agent that works by interfering with the growth and spread of cancer cells in the body.
Couldn't load pickup availability
Free shipping and returns available on all orders!
We ship all US domestic orders within 5-10 business days
CYTOSAR-U INJECTION is a sterile injectable formulation of Cytarabine, designed for the treatment of certain types of cancer, particularly acute myeloid leukemia (AML) and lymphomatous meningitis. It is a nucleoside analog that interferes with DNA synthesis, helping to inhibit the growth of cancer cells.
The dosage of CYTOSAR-U INJECTION is determined by the healthcare provider based on the patient's medical condition and response to treatment. It is typically administered intravenously or subcutaneously. Follow the prescribed dosage and schedule strictly.
Common side effects may include:
If you experience severe side effects or signs of an allergic reaction, seek medical attention immediately.
Inform your doctor about any allergies, medications you are currently taking, and any pre-existing health conditions.
CYTOSAR-U is not recommended for use during pregnancy. Discuss the risks and benefits with your healthcare provider.
CYTOSAR-U is administered by a healthcare professional, either intravenously or subcutaneously, depending on the treatment plan.
If you miss a dose, contact your healthcare provider for instructions. Do not double the dose to catch up.